Global Health Ventures to Present Live, Online at RetailInvestorConferences.com on August 4th
Global Health Ventures to Present Live, Online at RetailInvestorConferences.com on August 4th -- NEW YORK, Aug. 1, 2011 /PRNewswire/ --
Global Health Ventures to Present Live, Online at RetailInvestorConferences.com on August 4th
Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference
NEW YORK, Aug. 1, 2011 /PRNewswire/ -- Global Health Ventures Inc. (OTCBB: GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery announced today that Dr. Hassan Salari PhD, Chairman and CEO will be presenting at RetailInvestorConferences.com.
DATE: August 4, 2011
TIME: 7:00pm EDT
LINK: [ www.retailinvestorconferences.com ]>Click the red "register/ watch event now" button.
This will be a live, interactive online event where investors are invited to ask the company questions in real-time both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live in real-time, an on-demand archive will be available for 90 days.
It is recommended that investors [ pre-register to save time ] and receive event updates.
About Global Health Ventures
Global Health Ventures (GHLV.OB) is a specialty pharmaceutical company with expertise in drug delivery and formulation. The Company has developed a new formulation for drug delivery via the sublingual (under the tongue) route. This unique method delivers drugs to the bloodstream quickly with less drug breakdown in the liver or gastrointestinal system, a process that can reduce side effects associated with the drugs. The Company's lead therapeutic product is a male sexual enhancement drug that is delivered via sublingual route and is called X-Excite. In human studies, X-Excite has been shown to reach the blood stream faster than the oral route of delivery. The Company's second drug "Relax-B" is also under development in Canada for anxiety. And, the third drug will be an anti-migraine drug. The Company plans to use the same technology to deliver a vast number of other FDA approved drugs that require faster delivery, or reduced hepatic and gastrointestinal side effects. These include anti-stress, sleeping disorders, pain killers, anti-allergy medications, heart and lung medication, migraine and addiction replacement therapies.
About RetailInvestorConferences.com:
RetailInvestorConferences.com, created by [ BetterInvesting (NAIC) ], [ PR Newswire ] and [ MUNCmedia ], is the first monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.
SOURCE Global Health Ventures
[ Back to top ]